Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

NCT01047358 · clinicaltrials.gov ↗
COMPLETED
Status
206
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer